相关临床试验
2
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1968
已完成
2
100.0%
暂无批准数据
- Klotho Neurosciences is moving forward with manufacturing and process development for KLTO-202, an investigational gene therapy targeting amyotrophic lateral sclerosis (ALS). - The therapy utilizes a secreted alpha-Klotho (s-KL) RNA splice variant that has demonstrated neuroprotective effects in animal models of ALS, Alzheimer's disease, and rapid aging. - The company expects to complete manufacturing within eight months and begin Phase I/II clinical trials by the third quarter of next year following FDA approval processes. - KLTO-202 uses an AAV vector to deliver the s-KL gene directly to motor neurons, aiming to protect these cells from damage that leads to muscle paralysis and death in ALS patients.
• Scientists have developed the first wireless device capable of remotely activating photoactivable drugs, demonstrating effective pain management using photolabile morphine without typical opioid side effects. • The millimeter-sized implantable device uses NFC technology to wirelessly power a microLED that precisely releases active morphine only in targeted tissues, achieving comparable analgesic effects to systemic administration. • This photopharmacology breakthrough could revolutionize treatment for various conditions including epilepsy, Parkinson's disease, psychiatric disorders, and cancer by enabling localized drug delivery without systemic adverse effects.
- Fourteen lung cancer patients experienced unexpected hair darkening while receiving immunotherapy drugs including Keytruda, Opdivo, and Tecentriq at a Spanish hospital. - Thirteen of the 14 patients who showed hair repigmentation also demonstrated better treatment responses, suggesting hair darkening may indicate therapeutic efficacy. - The phenomenon represents the first reported case of hair repigmentation associated with immunotherapy for lung cancer, though the underlying mechanism remains unclear. - Researchers caution that while the findings are promising, extensive additional research is needed before any cosmetic applications could be developed.
